AI model improves recurrence risk stratification in HR-positive, HER2-negative breast

[News]

An artificial intelligence (AI) model created by integrating clinical, molecular, and histopathological data significantly improved recurrence risk stratification in hormone receptor (HR)-positive, HER2-negative breast cancer, according to results presented at the San Antonio Breast Cancer Symposium (SABCS), held December 9-12, 2025.

More... (https://www.news-medical.net/news/20251210/AI-model-improves-recurrence-risk-stratification-in-HR-positive-HER2-negative-breast-cancer.aspx)